(2E,4E,6Z,8E)-8-[6'-Methyl-3',4'-dihydro-1'(2'H)-naphthalen-1'-ylidene]-3,7-dimethyl-2,4,6-octatrienoic Acid

ID: ALA3289658

Chembl Id: CHEMBL3289658

PubChem CID: 59444434

Max Phase: Preclinical

Molecular Formula: C21H24O2

Molecular Weight: 308.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCc2cc(C)ccc21

Standard InChI:  InChI=1S/C21H24O2/c1-15(6-4-7-16(2)14-21(22)23)12-18-8-5-9-19-13-17(3)10-11-20(18)19/h4,6-7,10-14H,5,8-9H2,1-3H3,(H,22,23)/b7-4+,15-6-,16-14+,18-12+

Standard InChI Key:  KHXSEEGTXMJURJ-JUPRZYRNSA-N

Associated Targets(Human)

RARA Tclin Retinoic acid receptor alpha (1324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXRA Tclin Retinoid X receptor alpha (3637 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rxra Retinoid X receptor alpha (105 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 308.42Molecular Weight (Monoisotopic): 308.1776AlogP: 5.25#Rotatable Bonds: 4
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.55CX Basic pKa: CX LogP: 5.51CX LogD: 2.74
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.61Np Likeness Score: 0.98

References

1. Atigadda VR, Xia G, Desphande A, Boerma LJ, Lobo-Ruppert S, Grubbs CJ, Smith CD, Brouillette WJ, Muccio DD..  (2014)  Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.,  57  (12): [PMID:24801499] [10.1021/jm5004792]
2. Atigadda VR, Xia G, Deshpande A, Wu L, Kedishvili N, Smith CD, Krontiras H, Bland KI, Grubbs CJ, Brouillette WJ, Muccio DD..  (2015)  Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers.,  58  (19): [PMID:26331194] [10.1021/acs.jmedchem.5b00829]

Source